<DOC>
	<DOCNO>NCT02600494</DOCNO>
	<brief_summary>The study evaluate efficacy safety ITI-007 randomize , double-blind , parallel-group , placebo-controlled , multi-center study patient diagnose Bipolar I Bipolar II disorder major depressive episode .</brief_summary>
	<brief_title>Clinical Trial Evaluating ITI-007 Monotherapy Treatment Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Major male female subject race , age 1875 inclusive , clinical diagnosis Bipolar I Bipolar II disorder experience current major depressive episode Major subject unable provide inform consent female subject pregnant breastfeeding subject judge medically inappropriate study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>